Table 3

 Method comparison for ML-IAP detection in melanoma

NNegative (%)Positive (%)
IHC, immunohistochemistry; ISH: in situ hybridisation; ML-IAP, melanoma inhibitor of apoptosis protein; RT-PCR, reverse transcription polymerase chain reaction.
IHC versus ISH, p = 0.5937; IHC versus RT-PCR, p = 0.1523; ISH versus RT-PCR, p = 0.2625.
IHC3410 (29.4)24 (70.6)
ISH2810 (35.7)18 (64.3)
RT-PCR2111 (52.4)10 (47.6)